BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
Li A, Zhang R, Zhang Y, Liu X, Wang R, Liu J, Liu X, Xie Y, Cao W, Xu R, Ma Y, Cai W, Wu B, Cai S, Tang X.
Li A, et al. Among authors: zhang r, zhang y.
Am J Transl Res. 2019 Sep 15;11(9):5573-5585. eCollection 2019.
Am J Transl Res. 2019.
PMID: 31632530
Free PMC article.